Furthermore, this study sheds light on the roles of the ILK and TGF-β/SMAD2/3 signaling pathways in the development of MI and how these signaling pathways could be modulated by tamsulosin and hence contribute to its cardioprotective effect in the setting of MI. The gene discussed is SMAD2; the disease is myocardial infarction.